BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10846452)

  • 1. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R
    Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
    [No Abstract]   [Full Text] [Related]  

  • 2. No known cause: leukemia research.
    Tecnologica; 2000; ():1, 3-6, 14. PubMed ID: 11010680
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myeloid leukemia: progress and prospects].
    Baccarani M; Russo D; Fanin R
    Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
    Yao B; Guo M; Pian H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia].
    Etienne G; Mahon FX
    Bull Cancer; 2001 Jul; 88(7):651-8. PubMed ID: 11495816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stem cell transplantation for chronic myelogenous leukemia].
    Takayama N; Okamoto S
    Rinsho Ketsueki; 2000 Apr; 41(4):283-7. PubMed ID: 10846456
    [No Abstract]   [Full Text] [Related]  

  • 10. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myelogenous leukemia clinical practice guidelines in oncology.
    O'Brien S;
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S14-28. PubMed ID: 19795573
    [No Abstract]   [Full Text] [Related]  

  • 12. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
    Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha.
    Henic N; Preudhomme C; Noel M; Lai J; Wetterwald M; Simon M; Fenaux P
    Leukemia; 1996 Jan; 10(1):185-6. PubMed ID: 8558928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia].
    Tomonaga M
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2090-4. PubMed ID: 12187683
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of complications in patients with chronic myelogenous leukemia].
    Yoshida M
    Nihon Rinsho; 2001 Dec; 59(12):2410-5. PubMed ID: 11766348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.